Deal Type: Partnership Deal Sub Type: Co-development Deal Country: United States of America Deal Status: Completed Deal Value: 0.0000 USD Deal in Brief Schrodinger, Inc. , a provider of chemical simulation for pharma and biotech research, has ... 4 Traders, 3 weeks ago
2 images for "sanofi country"
Contextual Genomics and the Personalized Medicine Initiative (PMI) reported that Sanofi is the latest partner to join their National Access Project for Cancer Testing consortium. As part of its commitment to the project, Sanofi will provide a grant ...Individual.com, 1 day ago SANOFI : Added to National Access Project 4 Traders, 1 day ago
Sanofi is the newest partner in Consortium offering Canadian patients testing for cancer tumor mutations VANCOUVER--(BUSINESS WIRE)-- Contextual Genomics, a molecular diagnostics company developing genomic based cancer tests, and the ...CNBC, 6 days ago
Sanofi announced today that the U.S. Commerce Department's United States Patent and Trademark Office (USPTO) named the company one of 10 recipients of its prestigious "Patent for Humanity" award. Sanofi is being recognized for its patent that covers ...Individual.com, 1 week ago Sanofi to Receive Patent for Humanity Award at White House Africa News Wire, 1 week ago Sanofi Appoints Jean-Marie Arnaud As Senior Vice President And Head Of Sanofi Generics FirstWord Pharma, 2 weeks ago SunPower : U.S. Patent and Trademark Office Announces 2015 Patents for Humanity Winners 4 Traders, 1 week ago
By a News Reporter-Staff News Editor at Biotech Business Week Genzyme, a Sanofi company, announced that the Ministry of Health, Labor and Welfare (MHLW) has granted marketing approval for Cerdelga (INN: eliglustat), the only oral therapy for the ...Pharmacy Choice, 2 weeks ago Genzyme receives marketing approval from MHLW for Gaucher disease drug Individual.com, 2 weeks ago
To tap into the demand for affordable medication for the 6.5-crore-and-growing diabetic population in India, Shantha Biotechnics, an Indian arm of France-based pharma gaint Sanofi, has set up a new production facility to manufacture Insuman, a human insulin ...Asian Age, 2 months ago
Effect of Genzyme's multiple sclerosis treatment Lemtrada (alemtuzumab) on slowing brain atrophy and MRI lesion activity maintained through four years
Genzyme, a Sanofi company, has announced new magnetic resonance imaging ( MRI ) data from the Lemtrada® (alemtuzumab) clinical development program at the 67th American Academy of Neurology (AAN) Annual Meeting. In relapsing remitting multiple ...Medical News Today, 19 hours ago Genzyme Initiates Phase 2a Clinical Trial to Evaluate Oral Therapy for Fabry Disease Crawford Financial Planning, 6 days ago REG-Sanofi: Effect of Genzyme's Multiple Sclerosis Treatment Lemtrada(R) (alemtuzumab) on Slowing Brain Atrophy and MRI Lesion Activity Maintained Through Four Years Reuters, 4 days ago Sanofi: Effect of Genzyme's Multiple Sclerosis Treatment Lemtrada® (alemtuzumab) on Slowing Brain Atrophy and MRI Lesion Activity Maintained Through Four Years - HTML (w) WorldRegInfo, 4 days ago
In aviation, he pegged Kingfisher as the country's only luxurious airline and later acquired Air Deccan to foray into low-cost market. Emerging as one of the most flamboyant businessmen, he bought an IPL team (Royal Challengers Bangalore) and was ...DNA India, 21 hours ago Mallya: From bad to worse for 'King of Good Times' Press Trust of India, 21 hours ago
More from: , ZeeNews.com...and 2 other sources
Sanofi's ($SNY) highly anticipated dengue vaccine is being manufactured in a facility in France built specifically for the product. But expansion is also going on at Sanofi Pasteur's vaccine operation in Swiftwater, PA, in preparation for a launch ...IChainnel, 1 week ago Sanofi, others urge vaccination for food handlers Nigeria Punch, 1 week ago Sanofi 'flipping the model' for high-stakes dengue rollout FierceVaccines, 2 weeks ago Shantha starts supply of pentavalent vaccine The Financial Chronicle, 1 month ago
Innate Pharma and Sanofi collaborate on next generation antibody-drug conjugates using Innate's site-specific conjugation technology Marseille, France, April 16, 2015 /> Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), ...4 Traders, 1 week ago Innate Pharma and Sanofi collaborate on next generation antibody-drug conjugates - HTML (w) WorldRegInfo, 1 week ago REG-Innate Pharma and Sanofi collaborate on next generation antibody-drug conjugates Reuters, 1 week ago
on your WebpageAdd Widget >Get your members hooked!